Case Letter

Subcutaneous Panniculitic T-cell Lymphoma Presenting With Anasarca in a Patient With Known Chronic Lymphocytic Leukemia

Author and Disclosure Information

Practice Points

  • Subcutaneous panniculitic T-cell lymphoma (SPTCL) is a rare type of cutaneous T-cell lymphoma that may be complicated by fatal hemophagocytic syndrome.
  • Patients typically present with deep-seated plaques or nodules that may be masked by localized edema.
  • A biopsy is necessary to diagnose SPTCL, as well as to assess the degree of cellular atypia, fat necrosis, karyorrhexis, cytophagia, and angioinvasion to distinguish it from other panniculitides.
  • In patients with a known hematologic malignancy, a secondary malignancy must be considered in the differential diagnosis of paraneoplastic edema.


 

References

To the Editor:

Subcutaneous panniculitic T-cell lymphoma (SPTCL) is a rare cutaneous T-cell lymphoma that was first described in 19911 and comprises less than 1% of all non-Hodgkin lymphomas (NHLs). It most commonly occurs in young adults, with a median patient age of 36 years and a slight female predominance.2 Patients typically present with skin nodules or deep-seated plaques involving the legs, arms, and/or trunk. Presentation on the face is less common.2,3 Paraneoplastic edema has been reported in several cases of SPTCL with facial and periorbital swelling.4-9

Diagnosis of SPTCL is achieved via analysis of a deep tissue skin biopsy and close clinicopathologic correlation. Histopathology demonstrates lobular panniculitis with an atypical lymphoid infiltrate in the subcutaneous tissue with predominantly CD8+ T cells without overlying epidermotropism or interface dermatitis.3 The degree of cellular atypia, fat necrosis, karyorrhexis, cytophagia, and lack of angioinvasion can help to distinguish SPTCL from other panniculitides.2,3

The prognosis of SPTCL is good, with a 5-year survival rate of 82%, and many patients are able to achieve remission.2 However, SPTCL can progress to a fatal hemophagocytic syndrome, which has been reported in 17% of cases, making early diagnosis and treatment of this malignancy imperative.1,2 Treatment varies depending on the progression and extent of disease and can include the use of steroids, multidrug chemotherapy regimens, radiotherapy, and stem cell transplant in refractory cases.2-4,10,11

Subcutaneous panniculitic T-cell lymphoma with edema has been reported in a 2-year-old child.12 We present a case of SPTCL in an adult patient with known stage IV chronic lymphocytic leukemia (CLL) who also had full-body edema.

A 60-year-old woman with a 7-year history of stage IV CLL presented with anasarca of 3 months’ duration. At the time of presentation to dermatology, physical examination revealed erythematous tender nodules on the arms and legs. She had no other medical conditions and was undergoing treatment with ibrutinib for the CLL. The patient reported profound fatigue but no fever, chills, night sweats, cough, or dyspnea. The swelling had begun initially in the legs and progressively worsened to involve the arms, face, and body. She was hospitalized and treated with intravenous steroids and antihistamines, which led to minor improvement in the swelling. The patient’s preliminary diagnosis of erythema nodosum was thought to be related to the CLL or ibrutinib; therefore, treatment subsequently was discontinued and she was discharged from the hospital.

The swelling continued to worsen over the following 3 months, and the patient gained approximately 25 pounds. She presented to our office again with severe periorbital, facial, and lip edema as well as diffuse edema of the torso, arms, and legs (Figure 1). Erythematous tender subcutaneous nodules were noted on the right proximal thigh, left lateral calf, and forearms. She was again hospitalized, and extensive evaluation was performed to exclude other causes of anasarca, including a complete blood cell count; comprehensive metabolic profile; hepatitis panels; HIV test; C3 and C4, complement CH50, C1 esterase inhibitor, IgE, and angiotensin-converting enzyme levels; urine protein to creatinine ratio; computed tomography of the chest, abdomen, and pelvis; and allergy evaluation. The analyses failed to reveal the cause of the anasarca.

A, A 60-year-old woman with periorbital, facial, and lip edema. B, The lower extremities also showed edema, erythema, and a left lateral subcutaneous nodule (arrow).

FIGURE 1. A, A 60-year-old woman with periorbital, facial, and lip edema. B, The lower extremities also showed edema, erythema, and a left lateral subcutaneous nodule (arrow).

During hospitalization, the patient underwent a lymph node biopsy, bone marrow biopsy, and a 6-mm punch biopsy of the right thigh nodule. The lymph node and bone marrow biopsy results were consistent with the known diagnosis of CLL, and the patient was started on intravenous chemotherapy with bendamustine. The skin biopsy demonstrated a predominant T-cell infiltrate consistent with a lobular panniculitis with variable amounts of adipocytes rimmed by lymphocytes, nuclear debris, and karyorrhexis (Figure 2). CD3+, CD8+, and CD4 T cells were positive for T-cell receptor (TCR) βF1 and negative for TCR-γ with strong expression of cytotoxic markers including granzyme B, perforin, and T-cell intracytoplasmic antigen 1. Rare CD56+ cells also were noted. The biopsy did not demonstrate any notable interface dermatitis, epidermotropism, or angioinvasion. T-cell receptor gene rearrangement studies did not show clonality for γ- or β-chain probes. Subcutaneous panniculitic T-cell lymphoma was diagnosed, making this case unique with the presentation of anasarca. This case also is noteworthy due to the rare diagnosis of the secondary malignancy of SPTCL in a patient with known CLL. The patient opted to pursue hospice and comfort measures due to the effects of persistent pancytopenia and the progression of CLL. She died 2 months later.

A, A punch biopsy demonstrated a predominant T-cell infiltrate within the subcutaneous adipose tissue (H&E, original magnification ×4). B, Variable amounts of adipocytes rimmed by lymphocytes, nuclear debris, and karyorrhexis were shown on high power

FIGURE 2. A, A punch biopsy demonstrated a predominant T-cell infiltrate within the subcutaneous adipose tissue (H&E, original magnification ×4). B, Variable amounts of adipocytes rimmed by lymphocytes, nuclear debris, and karyorrhexis were shown on high power (H&E, original magnification ×200). C, An immunostain for T-cell receptor βF1 highlighted lymphocytes surrounding adipocytes (original magnification ×40).

Pages

Recommended Reading

Cutaneous T-Cell Lymphoma Treatment: Case Series of Combination Therapy With Intralesional Injections of 5-Fluorouracil and Topical Imiquimod
MDedge Dermatology
Chronic Ulcerative Lesion
MDedge Dermatology
Dissociating Fibroepithelioma of Pinkus From Internal Malignancy: A Single-Center Retrospective Study
MDedge Dermatology
Dome-Shaped Periorbital Papule
MDedge Dermatology
Dermoscopy, other modalities for improving melanoma diagnoses reviewed
MDedge Dermatology
Optimal management of dysplastic nevi continues to evolve
MDedge Dermatology
Violaceous Nodules on the Leg in a Patient with HIV
MDedge Dermatology
Epithelioma Cuniculatum (Plantar Verrucous Carcinoma): A Systematic Review of Treatment Options
MDedge Dermatology
Nicotinamide does not prevent skin cancer after organ transplant
MDedge Dermatology
FDA approves new Merkel cell carcinoma treatment
MDedge Dermatology